These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 32231026)

  • 1. Antibacterial Prodrugs to Overcome Bacterial Resistance.
    Jubeh B; Breijyeh Z; Karaman R
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32231026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel beta-lactam antibiotics derivatives: their new applications as gene reporters, antitumor prodrugs and enzyme inhibitors.
    Xing B; Rao J; Liu R
    Mini Rev Med Chem; 2008 May; 8(5):455-71. PubMed ID: 18473935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modification of existing antibiotics in the form of precursor prodrugs that can be subsequently activated by nitroreductases of the target pathogen.
    Çelik A; Yetiş G; Ay M; Güngör T
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4057-60. PubMed ID: 27390065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases.
    Rosales-Hurtado M; Sannio F; Lari L; Verdirosa F; Feller G; Carretero E; Vo-Hoang Y; Licznar-Fajardo P; Docquier JD; Gavara L
    ACS Infect Dis; 2023 Aug; 9(8):1546-1557. PubMed ID: 37439673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into Prodrugs of Quinolones and Fluoroquinolones.
    Sharma PC; Piplani M; Mittal M; Pahwa R
    Infect Disord Drug Targets; 2016; 16(3):140-161. PubMed ID: 27558786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Studies of an Aminoglycoside Potentiator Reveal a New Inhibitor of Aminoglycoside Resistance.
    Guan J; Vong K; Wee K; Fakhoury J; Dullaghan E; Auclair K
    Chembiochem; 2018 Oct; 19(19):2107-2113. PubMed ID: 30059603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of antimicrobial peptides and their prodrugs on model and biological membranes.
    Forde É; Shafiy G; Fitzgerald-Hughes D; Strömstedt AA; Devocelle M
    J Pept Sci; 2018 Jul; 24(7):e3086. PubMed ID: 29799150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sophisticated natural products as antibiotics.
    Lewis K; Lee RE; Brötz-Oesterhelt H; Hiller S; Rodnina MV; Schneider T; Weingarth M; Wohlgemuth I
    Nature; 2024 Aug; 632(8023):39-49. PubMed ID: 39085542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-Responsive Mesoporous Ruthenium for Combined Chemo-Photothermal Therapy of Drug-Resistant Bacteria.
    Liu Y; Lin A; Liu J; Chen X; Zhu X; Gong Y; Yuan G; Chen L; Liu J
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26590-26606. PubMed ID: 31264823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expanding role of prodrugs in contemporary drug design and development.
    Rautio J; Meanwell NA; Di L; Hageman MJ
    Nat Rev Drug Discov; 2018 Aug; 17(8):559-587. PubMed ID: 29700501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel heterodimer antibiotics: a review of recent patent literature.
    Long DD; Marquess DG
    Future Med Chem; 2009 Sep; 1(6):1037-50. PubMed ID: 21425993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting non-multiplying organisms as a way to develop novel antimicrobials.
    Coates AR; Hu Y
    Trends Pharmacol Sci; 2008 Mar; 29(3):143-50. PubMed ID: 18262665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial targets to antimicrobial leads and development candidates.
    Rogers BL
    Curr Opin Drug Discov Devel; 2004 Mar; 7(2):211-22. PubMed ID: 15603255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in drugs and prodrugs design of chitosan.
    Vinsova J; Vavrikova E
    Curr Pharm Des; 2008; 14(13):1311-26. PubMed ID: 18537655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enamide Prodrugs of Acetyl Phosphonate Deoxy-d-xylulose-5-phosphate Synthase Inhibitors as Potent Antibacterial Agents.
    Bartee D; Sanders S; Phillips PD; Harrison MJ; Koppisch AT; Freel Meyers CL
    ACS Infect Dis; 2019 Mar; 5(3):406-417. PubMed ID: 30614674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carvacrol prodrugs as novel antimicrobial agents.
    Marinelli L; Fornasari E; Eusepi P; Ciulla M; Genovese S; Epifano F; Fiorito S; Turkez H; Örtücü S; Mingoia M; Simoni S; Pugnaloni A; Di Stefano A; Cacciatore I
    Eur J Med Chem; 2019 Sep; 178():515-529. PubMed ID: 31207463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
    Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent antibacterial carbohydrate-based prodrugs, drugs and delivery systems to overcome antimicrobial resistance.
    Maria C; de Matos AM; Rauter AP
    Curr Opin Chem Biol; 2024 Feb; 78():102419. PubMed ID: 38219399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The landscape of small-molecule prodrugs.
    Fralish Z; Chen A; Khan S; Zhou P; Reker D
    Nat Rev Drug Discov; 2024 May; 23(5):365-380. PubMed ID: 38565913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.